Influence of red clover (Trifolium pratense) isoflavones on gene and protein expression profiles in liver of ovariectomized rats

Phytomedicine

Volumn 16, Issue 9, 2009, Pages 845-855

  Pakalapati, Geeta ^a   Li, Li ^a   Gretz, Norbert ^a   Koch, Egon ^b   Wink, Michael ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b DR WILLMAR SCHWABE GMBH AND CO KG   (Germany)

Author keywords

Antioxidant mechanisms; DNA microarray; Gene expression profiling; Lipid metabolism; Red clover

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; ISOFLAVONE DERIVATIVE; LOW DENSITY LIPOPROTEIN; RED CLOVER EXTRACT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DNA MICROARRAY; DRUG EFFECT; FEMALE; GENE CONTROL; GENE EXPRESSION PROFILING; LIPID METABOLISM; LIPOPROTEIN BLOOD LEVEL; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARIECTOMY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; RAT; RED CLOVER;

ANIMALS; ANTILIPEMIC AGENTS; ANTIOXIDANTS; CHOLESTEROL; FEMALE; GENE EXPRESSION; GENE EXPRESSION PROFILING; ISOFLAVONES; LIPID METABOLISM; LIVER; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OVARIECTOMY; PHYTOESTROGENS; PLANT EXTRACTS; PROTEOME; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TRIFOLIUM; TRIGLYCERIDES;

ANIMALIA; FABACEAE; RATTUS; TRIFOLIUM PRATENSE;

EID: 65549117159     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.phymed.2009.03.003     Document Type: Article

References (55)

1. Adlercreutz H. Phyto-oestrogens and cancer. Lancet Oncol. 3 (2002) 364-373
2. Adlercreutz H., Honjo H., Higashi A., Fotsis T., Hamalainen E., Hasegawa T., and Okada H. Urinary excretion of lignans and isoflavonoid phytoestrogens in Japanese men and women consuming a traditional Japanese diet. Am. J. Clin. Nutr. 54 (1991) 1093-1100
3. Adlercreutz H., and Mazur W. Phyto-oestrogens and western diseases. Ann. Med. 29 (1997) 95-120
4. Albert A., Altabre C., Baro F., Buendia E., Cabero A., Cancelo M.J., Castelo-Branco C., Chantre P.M., Duran J., Haya P., Impert P., Julia D., Lanchares J.L., Llaneza P., Manubens M., Minano A., Quereda F., Ribes C., and Vasquez F. Efficacy and safety of a phytoestrogen preparation derived from Glycine max (L.) Merr in climacteric symptomatology: a multicentric, open, prospective and non-randomized trial. Phytomedicine 9 (2002) 85-92
5. Anthony M.S., Clarkson T.B., Hughes Jr. C.L., Morgan T.M., and Burke G.L. Soybean isoflavones improve cardiovascular risk factors without affecting the reproductive system of peripubertal rhesus monkeys. J. Nutr. 126 (1996) 43-50
6. Arora A., Nair M.G., and Strasburg G.M. Antioxidant activities of isoflavones and their biological metabolites in a liposomal system. Arch. Biochem. Biophys. 356 (1998) 133-141
7. Barnes S., Peterson T.G., and Coward L. Rationale for the use of genistein-containing soy matrices in chemoprevention trials for breast and prostate cancer. J. Cell. Biochem. Suppl. 22 (1995) 181-187
8. Beck V., Unterrieder E., Krenn L., Kubelka W., and Jungbauer A. Comparison of hormonal activity (estrogen, androgen and progestin) of standardized plant extract for large scale use in hormone replacement therapy. J. Steroid Biochem. Mol. Biol. 1831 (2003) 1-10
9. Beck V., Jungbauer A., and Rohr U. Phytoestrogens derived from red clover: an alternative to estrogen therapy?. J. Steroid Biochem. Mol. Biol. 94 (2005) 499-518
10. Bennetts H.W., Underwood E.J., and Shier F.L. A specific breeding problem of sheep on subterranean clover pastures in Western Australia. Aust. J. Agric. Res. 22 (1946) 131-138
11. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72 (1976) 248-254
12. Brown M.S., and Goldstein J.L. Regulation of the mevalonate pathway. Nature 343 (1990) 425-430
13. Burdette J.E., Liu J., Lantvit D., Lim E., Booth N., Bhat K.P.L., Hedayat S., Van Breemen R.B., Constantinou A.I., Pezzuto J.M., Farnsworth N.R., and Bolton J.L. Trifolium pratense (red clover) exhibits estrogenic effects in vivo in ovariectomized Sprague-Dawley rats. J. Nutr. 132 (2002) 27-30
14. Cai Q., and Wei H. Effect of dietary genistein on antioxidant enzyme activities in SENCAR mice. Nutr. Cancer 25 (1996) 1-7
15. Cassidy A., Bingham S., and Setchell K. Biological effects of isoflavones in young women: importance of the chemical composition of soyabean products. Br. J. Nutr. 74 (1995) 587-601
16. Crouse J.R., Morgan T.M., and Terry J.G. A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins. Arch. Intern. Med. 159 (1999) 2070-2076
17. Cummings S., Eckert S., Krueger K., et al. The effect of raloxifene on risk of breast cancer in postmenopausal women. J. Am. Med. Assoc. 281 (1999) 2189-2197
18. Eaton E.A., Walle U.K., Lewis A.J., Hudson T., Wilson A.A., and Walle T. Flavonoids, potent inhibitors of the human P-form phenolsulfotransferase. Potential role in drug metabolism and chemoprevention. Drug Metab. Dispos. 24 (1996) 232-237
19. Fotsis T., Peper M., Adlercreutz H., Fleischmann G., Montesano R., and Schweigerer L. Genistein, a dietary-derived inhibitor of in vitro angiogenesis. Proc. Natl. Acad. Sci. USA 90 (1993) 2690-2694
20. Görg A. Two-dimensional electrophoresis with immobilized pH gradients: current state. Biochem. Soc. Trans. 21 (1993) 130-132
21. Görg A., Obermaier C., Boguth G., Harder A., Scheibe B., Wildgruber R., and Weiss W. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 21 (2000) 1037-1053
22. Görg A., Postel W., and Günther S. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 9 (1998) 531-546
23. Halliwell B. Antioxidants in human health and disease. Annu. Rev. Nutr. 16 (1996) 33-50
24. Howes J.B., Sullivan D., Lai N., Nestel P., Pomeroy S., West L., Eden J.A., and Howes L.G. The effects of dietary supplementation with isoflavones from red clover on the lipoprotein profiles of post menopausal women with mild to moderate hypercholesterolemia. Atherosclerosis 152 (2000) 143-147
25. Ibieta P.H., Zu Y., and Wink M. Binding of phytoestrogens to rat uterine estrogen receptors and human sex hormone-binding globulins. Z. f. Naturforschung 60c (2005) 649-656
26. Joannou G.E., Kelly G.E., Reeder A.Y., Waring M., and Nelson C. A urinary profile study of dietary phytoestrogens. The identification and mode of metabolism of new isoflavonoids. J. Steroid Biochem. Mol. Biol. 54 (1995) 167-184
27. Kaufman P.B., Duke J.A., Brielmann H., Boik J., and Hoyt J.E. A comparative survey of leguminous plants as sources of the isoflavones, genistein and daidzein: implications for human nutrition and health. J. Altern. Complement. Med. 3 (1997) 7-12
28. Klose J. Protein mapping by combined isoelectric focusing and electrophoresis of mouse tissues. A novel approach to testing for induced point mutations in mammals. Humangenetik 26 (1975) 231-243
29. Klose J., and Kobalz U. Two-dimensional electrophoresis of proteins: an updated protocol and implications for a functional analysis of the genome. Electrophoresis 16 (1995) 1034-1059
30. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
31. Kroyer G.Th. Red clover extract as antioxidant active and functional food ingredient. Innovative Food Sci. Emerging Technol. 5 (2004) 101-105
32. Martin M.E., Haourigui M., Pelissero C., Benassayag C., and Nunez E.A. Interactions between phytoestrogens and human sex steroid binding protein. Life Sci. 58 (1996) 429-436
33. Nestel J.P., Pomeroy S., Kay S., Komesaroff P., Behrsing J., Cameron D.J., and West L. Isoflavones from red clover improve systemic arterial compliance but not plasma lipids in menopausal women. J. Clin. Endocrinol. Metab. 84 (1999) 895-898
34. Ntukidem N.I., Nguyen A.T., Stearns V., Rehman M., Schott A., Skaar T., Jin Y., Blanche P., Li L., Lemler S., Hayden J., Krauss R.M., Desta Z., Flockhardt D.A., Hayes D.F., and Consortium on Breast Cancer Pharmacogenomics. Estrogen receptor genotypes, menopausal status, and the lipid effects of tamoxifen. Clin. Pharmacol. Ther. 83 (2008) 702-710
35. O'Farrell P.H. High resolution two-dimensional electrophoresis of proteins. J. Biol. Chem. 250 (1975) 4007-4021
36. Peterson G., and Barnes S. Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells. Cell Growth Differ. 7 (1996) 1345-1351
37. Pfaffl M.W., Horgan G.W., and Dempfle L. Relative Expression Software Tool (REST©) for group wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res. 30 (2002) E36
38. Potter S.M. Soy protein and serum lipids. Curr. Opin. Lipidol. 7 (1996) 260-264
39. Price K.R., and Fenwick G.R. Naturally occurring oestrogens in foods - a review. Food Addit. Contam. 2 (1985) 73-106
40. Record I.R., Dreosti I.E., and McInerney J.K. The antioxidant activity of genistein in vitro. Nutr. Biochem. 6 (1995) 481-485
41. Reynaud J., Guilet D., Terreux R., Lussignol M., and Walchshofer N. Isoflavonoids in non-leguminous families: an update. Nat. Prod. Rep. 22 (2005) 504-515
42. Saija A., Scalese M., Lanza M., Marzullo D., and Bonina F. Flavonoids as antioxidant agents: importance of their interaction with biomembranes. Free Rad. Biol. Med. 19 (1995) 481-486
43. Saija A., Tomaino A., Trombetta D., Giacchi M., Pasquale A.D., and Bonina F. Influence of different penetration enhancers on in vitro skin permeation and in vivo photoprotective effects of flavonoids. Int. J. Pharm. 175 (1998) 85-94
44. Setchell K.D.R. Phytoestrogens: biochemistry, physiology, and implications for human health of soy isoflavones. Am. J. Clin. Nutr. 68 (1998) 1333S-1346S
45. Setchell K.D.R. Soy isoflavones - benefits and risks from nature's selective estrogen receptor modulators (SERMs). J. Am. Coll. Nutr. 20 (2001) 354s-362s
46. Setchell K.D.R., and Adlercreutz H. Mammalian lignans and phyto-oestrogens. Recent studies on their formation, metabolism and biological role in health and disease. In: Rowland I.R. (Ed). Role of the Gut Flora in Toxicity and Cancer (1988), Academic Press, London, UK 315-345
47. Sherwin E.R. Oxidation and antioxidants in fat and oil processing. J. Am. Oil Chem. Soc. 55 (1978) 809-814
48. Tresguerres J.A.F., Castillo C., Salazar V., Ariznavarreta C., and Varaand E. Effect of isoflavone administration on age-related hepatocyte changes in old ovariectomized female Wistar rats. Phytomedicine 13 (2006) 468-476
49. Van Acker S.A.B.E., Van Den Berg D.J., Tromp M.N.J.L., Griffioen D.H., Van Bennekom W.P., Van Der Vijgh W.J.F., and Bast A. Structural aspects of antioxidant activity of flavonoids. Free Rad. Biol. Med. 20 (1996) 331-342
50. Vieria M.L.T., Duarte R.F., Campos L.M.M., and Nunan E.A. Comparison of the estrogenic potencies of standard soy extracts by immature rat uterotrophic bioassay. Phytomedicine 15 (2007) 31-37
51. Wei H., Bowen R., Cai Q., Barnes S., and Wang Y. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc. Soc. Exp. Biol. Med. 208 (1995) 124-130
52. Wei H., Wei L., Frankel K., Bowen R., and Barnes S. Inhibition of tumor promoter induced hydrogen peroxide formation in vitro and in vivo by genistein. Nutr. Cancer 20 (1993) 1-12
53. Wilcox J.N., and Blumenthal B.F. Thrombotic mechanisms in atherosclerosis: potential impact of soy proteins. J. Nutr. 125 (1995) 631S-638S
54. Yamamoto S., Shimizu K., Oonishi I., Hasebe K., Takamura H., Inone T., Muraoka K., Tani T., Hashimoto T., and Yagi M. Genistein suppresses cellular injury following hepatic ischemia/reperfusion. Transplant. Proc. 28 (1996) 1111-1115
55. Yamashita Y., Kawada S.Z., and Nakaro H. Induction of mammalian topoisomerase II dependent DNA cleavage by nonintercalative flavonoids, genistein and orobol. Biochem. Pharmacol. 39 (1990) 737-744